Skip to main content
. 2020 Aug 22;15:1–15. doi: 10.1016/j.ejcsup.2020.02.001

Fig. 3.

Fig. 3

Clinicopathological and molecular features of mucinous ovarian carcinomas (MOC). Hematoxylin–eosin staining of a borderline tumour (A); MOC with expansive (B) and infiltrating pattern (C); mutated p53 expression (D), HER2 overexpression (E) and silver in situ hybridization (SISH) of ERBB2 amplification (F). 1precursor: mucinous borderline tumour, 2median age at diagnosis.